Catálogo de publicaciones - libros
Título de Acceso Abierto
New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
apolipoprotein; lipids; risk stratification; proprotein convertase subtilisin-kexin type 9 (PCSK9); vaspin; sphingolipids; PCSK9; ceramides; atrial fibrillation; circular RNA; STEMI; cholesterol; lipoproteins; cardiovascular disease (CVD); coronary artery bypass grafting; atherosclerosis; statin; LDL subfractions; acute kidney injury; dyslipidemia; gene expression; NSTEMI; NAFLD; hyperlipidemia; nonstatin; cholesteryl ester transfer protein; low-density lipoprotein cholesterol; anacetrapib; HDL; acute coronary syndrome; miRNA; cardiovascular risk; pleiotropic actions; genetic; ABCA1; sdLDL; cardiovascular disease; proprotein convertase subtilisin/kexin type 9; inclisiran; reverse cholesterol transport; sterol; small interfering RNA (siRNA); RNA-binding proteins; cardiovascular diseases; NASH; low-density lipoprotein-cholesterol (LDL-C); stroke; nutrigenetics; type 2 diabetes; statins; sphingomyelin; hepatic fibrosis; diabetes
Disponibilidad
| Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
|---|---|---|---|---|
| No requiere | Directory of Open access Books |
|
Información
Tipo de recurso:
libros
ISBN electrónico
978-3-03921-677-2
País de edición
Suiza